Developing a Research Agenda to Prevent and Control
CVD in Central Appalachia
Patients, Caregivers, Providers, Public Health Professionals, Community Stakeholders
CVDAppalachia Conference II: August 30, 2019
Holiday Inn, Johnson City, Tennessee
8:00 am—5:00 pm
Notable Guest Speakers ● Complimentary Meals ● Poster Presentations ● Exhibitors/Vendors
To register for CMEs, please visit https://www.etsu.edu/com/cme/cvd_2019.php.
There is no registration fee for this event.
However, pre-registration is required for anyone seeking CME credit or attendance credit.
This CVD community engagement award project, funded by Patient-Centered Outcomes Research Institute, is focused on quality improvement strategies and a better understanding of effective policies/programs for Central Appalachia.
This Conference is Free and Catered
(Breakfast, Lunch, and Snacks)
The 1st 50 patients/non-licensed caregivers will receive $20.
CME Credits Available for Eligible Participants
Plenary Session Panel of Experts
CVD affects both youths and adults and CVD-related risk factors are prevalent in both populations. The conference will try to understand the issue of access to and utilization of health services by both populations and provision of health services by health systems in the region. Thus, there will be discussion of barriers and challenges to access and utilization of CVD health services unique to Central Appalachia. Integral part of these discussions will be health/information literacy to support better health outcomes among CVD patients.
It is the underlying cause of the majority of CVD. Research suggests that the knowledge about atherosclerosis in environments similar to Central Appalachia is low. Therefore, there will be discussions of how to enhance knowledge about atherosclerosis, including subclinical ones such as coronary artery calcium, CT Angiogram, Ankle Brachial Index, and C-reactive protein. The discussions during this session will include co-morbidities and co- occurrence of CVD and CVD prevention through screening, among others.
Risk Factors/Social Determinants
Traditional risk factors for CVD are well established, including medical conditions (diabetes, obesity, hypertension, and hypercholesterolemia), lifestyle/behavior (smoking, unhealthy diet, and physical inactivity), and structural/social determinants (poverty, unemployment, education, and income). Yet, over 85 million Americans have at least one risk factor. Indeed, we found in our research involving a Central Appalachian population that over 90% of the participants had more than one CVD risk factor. While these CVD risk factors may be ubiquitous, some may be highly prevalent in certain population subgroups and geographic areas. As such, the conference will explore the factors that are of priority to communities in Central Appalachia and needing urgent attention, which is consistent with the comparative effectiveness research framework.
CVD Policies and Programs
The Institute of Medicine (IOM) has opined that policies/programs can be used to achieve positive health outcomes and improve population health status. Evidence indicates that policy/programmatic changes have contributed to the overall decline in CVD morbidity and mortality in the U.S. However, these policies and programs have desperate impacts on population subgroups and geographic areas. Indeed, these nationwide or statewide policies/programs have not had the expected outcomes on CVD and its risk factors in Central Appalachia, which is why the prevalence continues to be high. Therefore, this session will discuss evidence-based policies developed and implemented within communities across Central Appalachia.
Research suggests that more than half of patients in the United States do not adhere to their medication regimen as prescribed by their medical/health providers. The non-adherence to medication regimen has several adverse implications such as hospitalization (including readmissions) and health care costs. Given the high prevalence of CVD in Central Appalachia, it is important to discuss the issue of medication adherence in a conference involving patients/families, medical/health practitioners, and other stakeholders.
CVD and Culture
It has been established that Appalachia has a unique culture, which underpins the health outcomes and health behaviors of the people in the region. As such, this section will discuss the socio-culture dynamics involved in CVD prevention and treatment.
Managing Patient Population
The Institute of Medicine (IOM) has developed 15 goals to assess the health status of a population, point 10 of which addresses the issue of cardiovascular health. As such, the discussions during this session will involve how to assess and improve the cardiovascular health status of the population in Central Appalachia, given that CVD related issues span from subclinical atherosclerosis in asymptomatic patients to cardiovascular hard events such as Acute Myocardial Infarction and Sudden Cardiac Deaths. An integral part of this discussion will be how to reach CVD patients/caregivers using modern technology, including telemedicine and mHealth. For example, the conference will provide forum for the discussion of how to use Short Message Services (SMS) to enhance medication adherence or increase the rate of attendance for physician appointments. Further, the use of Electronic Medical Record systems to manage and improve patients’/stakeholders’/policymakers’ knowledge of CVD and health outcomes will be explored. Moreover, the discussions of this session will encompass development of CVD databases for individual and population-based studies for the Central Appalachian region. Thus, several components of how to use technology to improve the health outcomes of CVD patient population will be explored and used to inform the research agenda for Central Appalachia.
Special Session: “Poster Presentations”
Call for Abstracts
The call for abstracts for the CVD Appalachia Conference, August 30, 2018 is now open! Submissions will be accepted beginning March 15, 2018. Submissions received after May 15, 2018 will not be accepted for consideration. We welcome abstracts on any CVD/CVD risk factor related topic. Abstracts will be accepted for consideration by the Scientific Committee. Notification of acceptance will be made no later than May 31, 2018.
Each abstract submission should include authors’ names, affiliation, and the corresponding author’s contact information. A 250-word structured abstract (introduction, method, results, and discussion) is expected.
Abstracts should be submitted online through our website or emailed directly to our Project Coordinator, Amy Poole, MS, at email@example.com.
At least one of the coauthors needs to be a registered member of CVD Appalachia conference. When submitting the abstract, please indicate which coauthor(s) will register and present. CVD Appalachia is open to all. To register, please visit www.etsu.edu/cvdappalachia.
The Best Abstract Award: All authors, whether submitting through individual abstracts, have the option to indicate whether this abstract will compete for “Best Abstract Award.” The winner will have their abstract and poster published on the CVD Appalachia website, plus receive a Certificate of Merit.
Be part of the Conversation
Join ♥ Participate ♥ Collaborate
For Special Rates on Lodging visit:
Holiday Inn or call (423) 282-4611.
For more information, contact: Amy M. Poole, MS, Project Coordinator,
firstname.lastname@example.org or call (423) 845-4021. Someone will respond within 24 hours.